21:15 , May 18, 2018 |  BioCentury  |  Finance

China comes to Europe

  The historically underfunded European biotech sector is in the early stages of tapping into a new stream of capital thanks to the explosion of biomedical innovation in China, which has spawned a wave of investors...
15:23 , Apr 13, 2018 |  BC Week In Review  |  Company News

Orchard gains GSK's rare disease gene therapy portfolio

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) said it will divest its rare disease gene therapy portfolio, including Strimvelis, to Orchard Therapeutics Ltd. (London, U.K.). GSK will be eligible to receive undisclosed commercial milestones and royalties. The pharma will...
15:48 , Apr 12, 2018 |  BC Extra  |  Company News

Orchard gains GSK's rare disease gene therapy portfolio

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) said it will divest its rare disease gene therapy portfolio, including Strimvelis, to Orchard Therapeutics Ltd. (London, U.K.). GSK will be eligible to receive undisclosed commercial milestones and royalties. The pharma will...
18:32 , Dec 22, 2017 |  BioCentury  |  Finance

Orchard’s supply

Promising early data for a rare disease lentiviral gene therapy from Orchard Therapeutics Ltd. helped the Orphan disease company raise a $110 million series B round that it thinks will be enough to carry its...
15:01 , Dec 22, 2017 |  BC Week In Review  |  Financial News

Orchard raises $110M series B

Gene therapy company Orchard Therapeutics Ltd. (London, U.K.) raised $110 million in a series B round led by Baillie Gifford and ORI Capital. Fellow new investors Temasek, Cowen Healthcare Investments, Juda Capital, Pavilion Capital, RTW...
09:54 , Dec 20, 2017 |  BC Extra  |  Financial News

Orchard raises $110M series B

Gene therapy company Orchard Therapeutics Ltd. (London, U.K.) raised $110 million in a series B round led by Baillie Gifford and ORI Capital. Fellow new investors Temasek, Cowen Healthcare Investments, Juda Capital, Pavilion Capital, RTW...